Chris Tibbitt Dr Jane Falconer Dr Jeroen Stoop Emeritus Professor John Robinson Professor Catharien Hilkens et al. | Reduced TCR-dependent activation through citrullination of a T-cell epitope enhances Th17 development by disruption of the STAT3/5 balance | 2016 |
|
Dr Jeroen Stoop Chris Tibbitt Professor John Robinson Professor Catharien Hilkens
| The choice of adjuvant determines the cytokine profile of T cells in proteoglycan-induced arthritis but does not influence disease severity | 2013 |
|
Dr Gillian Bell Dr Amy Anderson Dr Rachel Harry Dr Jeroen Stoop Professor Catharien Hilkens et al. | Autologous tolerogenic dendritic cells in rheumatoid arthritis | 2012 |
|
Dr Jeroen Stoop Professor John Robinson Professor Catharien Hilkens
| Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models? | 2011 |
|
Harriet Purvis Dr Jeroen Stoop Professor Jelena Mann Steven Woods Anne Kozijn et al. | Low strength T-cell activation promotes Th17 responses | 2010 |
|
Dr Jeroen Stoop Professor Jelena Mann Steven Woods Anne Kozijn Professor Sophie Hambleton et al. | Low-strength T-cell activation promotes Th17 responses | 2010 |
|
Dr Jeroen Stoop Professor John Robinson Professor Catharien Hilkens
| The choice of adjuvant determines the cytokine profile of T cells in proteoglycan induced arthritis | 2010 |
|
Dr Jeroen Stoop Dr Rachel Harry Dr Alexei von Delwig Professor John Isaacs Professor John Robinson et al. | Therapeutic Effect of Tolerogenic Dendritic Cells in Established Collagen-Induced Arthritis Is Associated With a Reduction in Th17 Responses | 2010 |
|
Dr Jeroen Stoop Dr Alexei von Delwig Professor John Isaacs Professor John Robinson Professor Catharien Hilkens et al. | Immunotherapy with tolerogenic dendritic cells inhibits the progression of collagen-induced arthritis | 2008 |
|